Pharma AI & IoT 2018
Offering our customers the knowledge and connections for a profitable business
Speakers
  • MARGARET McDONALD

    MARGARET McDONALD PFIZER (USA)

  • SHWEN GWEE

    SHWEN GWEE Biogen (USA)

  • JAMES WEATHERALL

    JAMES WEATHERALL AstraZeneca

  • DARREN GREEN

    DARREN GREEN GSK

  • HERVE DUMAS

    HERVE DUMAS UCB

  • GABOR PURMAN

    GABOR PURMAN Teva Pharmaceuticals

  • PETER RUTHERFORD

    PETER RUTHERFORD Vifor Pharma

  • NATHALIE LAHITTE

    NATHALIE LAHITTE Lundbeck

  • SHERAZ MAJEED

    SHERAZ MAJEED NHS

  • SLAVA AKMAEV

    SLAVA AKMAEV BERG (USA)

  • FINN CATLING

    FINN CATLING University College London Hospitals NHS Foundation Trust

  • RAMINDERPAL SINGH

    RAMINDERPAL SINGH Eagle Genomics

  • JORGE ARMANET M

    JORGE ARMANET M HealthUnlocked

  • PAUL MICHAEL AGAPOW

    PAUL MICHAEL AGAPOW Imperial College London

  • PAUL HARTIGAN

    PAUL HARTIGAN PharmiWeb Solutions

  • MARIE MONTOYA

    MARIE MONTOYA M Montoya Consultancy

  • AXEL SCHUMACHER

    AXEL SCHUMACHER Project Shivom

  • PASQUALE FEDELE

    PASQUALE FEDELE LIQUIDWEB

  • RYO SAKAI

    RYO SAKAI PharmiWeb Solutions

11th & 12th July 2018, Canary Riverside Plaza Hotel, London UK

Integrating AI, IoT, Cloud & Big Data Analytics in Pharma & Healthcare

ADD THIS EVENT TO YOUR CALENDAR
Sponsors & Exhibitors
  • Conference Info
  • Day One
  • Day Two
  • Speakers
  • Sponsors
  • Partners
  • Sponsorship Opportunity
  • Delegates
  • Pricing
  • Venue
  • Testimonials

CONFERENCE INTRODUCTION:-

There needs to be a fundamental shift in drug discovery and artificial Intelligence holds the key to bringing the pharma industry into the 21st Century. From discovery and development and through the entire product lifecycle, artificial intelligence (AI) is starting to shake up the life-sciences industry. The potential of intelligent apps (i.e., apps that are capable of learning from experience) is so far-reaching that it is expected that AI-enabled drugs will be brought to market in the near future. A Silicon Valley Bank analysis last month found that 44 venture-backed deals raised $2.2 billion between 2015 and the first half of 2017 for Dx/Tools companies that use AI/ML as part of their underlying technology. A report from Aruba states that 60 percent of health care organizations across the world have started using the internet of things in their facilities. Current uses include insulin delivery, activity trackers for cancer treatment, ingestible sensors, depression-fighting apps, and more.

A growing need for healthier lifestyles coupled with breakthrough technological innovation has been instrumental in boosting adoption, and the global IoT healthcare market is expected to grow from USD32.4 Bn in 2015 to USD163.2 Bn by 2020, a CAGR of 38.1%. One of the world’s biggest markets for healthcare services, the United States spends approximately 18% of its GDP on healthcare every year. By improving adherence to prescribed therapies alone, the US could significantly reduce their healthcare spends. The effective deployment of IoT-based healthcare delivery technologies could help the US save well over USD 300 billion

Our Pharma AI & IoT 2018 will provide insight into the current state of play in the EU & US and stimulate debate, in a multi-stakeholder setting, on the vital role of techonologyy impact in the sustainability of pharma and healthcare systems. Beyond a comprehensive outlook of key European market access policies,  our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. By attending this conference, you will gain a comprehensive outlook on the key issues surrounding latest technologies that are being analysed towards the pharma and healthcare. This event will provide an important platform for stakeholders to discuss and share best practices in furthering technology development in pharma and healthcare

It gives me great pleasure in welcoming all of you to the Virtue Insight’s Pharma AI & IoT 2018.


KEY THEMES:-

  • Market overview and Analysis
  • Shaping the future of AI in Pharma
  • AI for Precision Medicine
  • How AI technology can accelerate, cheapen and De-Risk R&D
  • Machine learning in patient stratification, genomic analysis, population investigation and real world data
  • Exploring R&D applications in machine learning
  • AI - Challenges exist, but opportunities beckon
  • Scaling your business with implementation of AI
  • AI to increase pharma innovation
  • IoT & IIoT - The new Rx for pharma manufacturing & supply chains
  • Cyber Security is Critical in an Age of IoT and Healthcare Hacks
  • Big Pharma, Big Data - Big Deal? Yes, Really!
  • How big data can revolutionise pharmaceutical R&D
  • Promise and challenge of Big Data for Pharma
  • Pharma to open up big data for clinical trials, analytics
  • Clinical Trials innovations with big data and advanced analytics era
  • IoT could save billions in healthcare costs across the US and Europe
  • Differences that Internet of Things (IoT) Can Make to Healthcare
  • How IoT is poised to transform the world of pharma
  • Developing regulatory framework in advanced and developing markets – for Today & Tomorrow
  • Moving beyond 5 years – What will the technology landscape look like?
  • Be part of a major networking opportunity

 

WHO SHOULD ATTEND:-

CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors, Team Leaders, Evangelists and Senior Scientists from the following areas:

  • Pharmaceuticals
  • Biotech
  • Artificial Intelligence
  • Data Science
  • Machine Learning
  • IoT
  • Cloud
  • Advanced Analytics
  • Innovation
  • Big Data
  • Deep Learning
  • Bioinformatics
  • Regulatory Compliance
  • New Product Development
  • Process Science
  • Portfolio Management
  • Research & Development
  • Business Development
  • Business Operations
  • Scientific Affairs
  • Commercial Affairs
  • Marketing

 

WHY SHOULD YOU ATTEND:- 

Get more from the event, enjoy and make the best out of our dedicated networking drinks time, meet the leading international vendors showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference. Whether you are on the branded or generic side, you cannot afford to miss this opportunity to benchmark your tactics and strategies against the industry leaders who will be the first to traverse the pathway. Devise an immediate action plan for your biosimilar prosecution and litigation strategies in light of the barriers to entry, research and development costs, and regulatory hurdles, which are balanced against an enormous potential for increased profit margins.

08:30 – Coffee and registration – An opportunity to meet and network with your conference colleagues.

09:30 – Chairperson opening remarks
PAUL HARTIGAN, CEO, PharmiWeb Solutions


MARKET OVERVIEW & ANALYSIS


09.40 – Shaping the future of AI in Pharma

  • What’s holding back the application of AI in Pharma?
  • Exploring R&D applications in machine learning
  • Revolutionizing Pharmaceutical Culture and Process Towards the Integration of AI
  • How AI technology can accelerate, cheapen and De-Risk R&D
  • Showcasing the Utility of AI in Early Stages of R&D to Prove This Disruptive Technology’s Validity
  • AI initiative towards drug discovery

DARREN GREEN, Director, Molecular Design UK, RD Platform Technology & Science, GSK

10:20 – AI for Precision Medicine

  • How AI can revolutionize personalized medicine and patient care
  • Machine learning in patient stratification, genomic analysis, population investigation and real world data
  • Unlocking novel insights on patients to improve drug development and efficacy
  • How to best action AI and smart learning algorithms to use biomedical big data
  • Algorithmic responsibility: Who holds accountability for the downstream effects of AI based decision-making?

PAUL MICHAEL AGAPOW, Head of Translational Bioinformatics, Data Science Institute, Imperial College London

11:00 – Morning Coffee/Tea & Discussion

CHALLENGES & OPPORTUNITIES

11:20 – Keynote Panel Discussion: AI - Challenges exist, but opportunities beckon

  • Will AI/ML-focused approaches actually drive more accurate diagnoses and improve healthcare?
  • How quickly will regulatory bodies and payers approve and adopt these approaches?
  • Preparing for the Implications of “Brexit” in the Pharmaceutical Industry
  • Investors point of view
  • How are digital technologies impacting pharma industry
  • AI, IoT and blockchain in precision medicine
  • Future of next generation AI

Moderator:
PAUL HARTIGAN, CEO, PharmiWeb Solutions


Panellists:
RAMINDERPAL SINGH, Vice President, Head of Microbiome Division, Eagle Genomics
SLAVA AKMAEV, Senior Vice President, Chief Analytics Officer, Co-founder, Berg Healthcare (USA)
JORGE ARMANET M, CEO & Co-Founder, HealthUnlocked
FINN CATLING, ACCS Anaesthetics CT1 Doctor, University College London Hospitals NHS Foundation Trust
AXEL SCHUMACHER, Co-Founder & CEO, Project Shivom


12:00 – Solution Provider Presentation
For sponsorship opportunities please contact info.uk@virtueinsight.com


ARTIFICIAL INTELLIGENCE

12:20 – Solution Provider Presentation
For sponsorship opportunities please contact info.uk@virtueinsight.com

12:40 Networking luncheon

13:50 – Scaling your business with implementation of AI

  • Get an accurate understanding of AI, what it is, and what it is not
  • Understand your operational blueprint and where AI fits
  • Recognise the benefits and opportunities of implementing AI
  • Navigate potential risks and challenges of AI implementation
  • Define your vendor selection criteria and make the best selection based on business operations
  • Challenges and obstacles faced by manufacturers in developent process

NATHALIE LAHITTE, Digital Marketing Manager, Lundbeck

14:30 De-risking drug discovery through automation of data discovery
RAMINDERPAL SINGH, Vice President, Head of Microbiome Division, Eagle Genomics

14:50 BrainControl: AI for Human-Machine interaction
PASQUALE FEDELE, CEO & Founder, LIQUIDWEB

15:20 – Afternoon Tea/Coffee

15:40 AI and Big Data in clinical development and patient stratification

  • Precision Medicine has been a buzz word for several years, can the industry implement precision medicine approaches in clinical trials?
  • BERG has been on the forefront of using multi-omic data and AI driven analytics for de novo biomarker discovery in clinical development
  • The talk will focus on a specific case study in oncology: Translation of novel discovery in phase I into validation in phase II and actionable patient stratification in phase III
  • Can we expedite clinical development with precise patient selection? Is it possible to complete trials in phase II if the right patients are enrolled?

SLAVA AKMAEV, Senior Vice President & Chief Analytics Officer, BERG (USA)

16:10 – Panel Discussion - Digital innovation in healthcare and pharma industry

  • How is digital changing the pharma & healthcare industry
  • Digital Trends in Healthcare and Pharma
  • Payors, Stake holders, Pharmacists and patients - Their roles and the implications
  • Challenges and Opportunities
  • Understand your digital objectives and identify the means to achieve them

Moderator:
PAUL HARTIGAN, CEO, PharmiWeb Solutions

Panellists:
GABOR PURMAN, Associate Director Global Respiratory Development in Patient Solutions Team, Teva Pharmaceuticals

16:50 Chairperson’s closing remarks and end of conference


17:00 – 18:00 Networking Drinks Session

08:30 – Coffee and registration – An opportunity to meet and to network with your conference colleagues.

09:30 – Chairperson opening remarks
PAUL HARTIGAN, CEO, PharmiWeb Solutions


BIG DATA & ADVANCED ANALYTICS

09:40 – Optimizing RWD to meet the evolving evidence needs  of pharma

  • Current state of affairs of Real World Data (RWD)
  • External Environment: Updates on regulatory agencies’ use of RWD and collaborations
  • Uses of RWD across Life Cycle

MARGARET McDONALD, Senior Director, Real World Data & Analytics, Patient & Health Impact, PFIZER (USA)

10:20 – Why Chatbots are the future of healthcare?

SHWEN GWEE, Head of Digital Strategy, Global Clinical Operations, Biogen (USA)

11:00 – Morning Coffee/Tea & Discussion

11:20 – Clinical trials – today and tomorrow

  • A view on why the clinical trials of today are unsustainable
  • Examples of where AI, IoT, big data are succeeding in shifting the paradigm
  • A perspective on how all of this may fundamentally change the way the world conducts clinical research in the future

JAMES WEATHERALL, Executive Director and Head of Advanced Analytics Centre, AstraZeneca

12:00 – Digital Innovation in Pharma

  • Data Visualisation - From numbers to narratives: new ways of unlocking the value in complex data to help explain the underlying science to healthcare professionals
  • VR and AR - Using Virtual and Augmented Reality to create better engagement and deeper understanding of complex science and data

RYO SAKAI, Data Visualization & Scientific Communications Lead, PharmiWeb Solutions

12:30 – Networking luncheon

13:30 – Blockchain and Healthcare Systems

  • How Blockchain is changing the world
  • Major Disruptive Technology
  • Are we Ready for it
  • Suggestions for integrating Blockchain with healthcare systems

SHERAZ MAJEED, Palliative Medicine Consultant, NHS

14:00 – Managing data effectively
MARIE MONTOYA, Director, M Montoya Consultancy

INTERNET OF THINGS

14:20 – Differences that Internet of Things (IoT) Can Make to Healthcare

  • With all the imaginative, nay, fanciful solutions to real-world problems that IoT can deliver, the healthcare industry has a lot to gain.
  • Convenience — Through Easy Access and Reach
  • Constant Monitoring — Through Wearable Devices
  • Better Diagnosis — Through Big Data and Analytics
  • Accurate Tracking — Data, Patients, equipment & personnel
  • Cost Reduction — Through preventive, predictive, and pervasive solutions

PETER RUTHERFORD, Medical Lead, Renal Orphan, Vifor Pharma

14:50 How IoT is poised to transform the world of pharma

  • For Pharma – IoT benefits - facilitating data analysis and remote access to equipment, streamlining efficiencies and preventing counterfeiting
  • Data Collection and Analysis
  • Remote Access
  • Track and Trace
  • Sourcing IoT Solutions
  • Oncology Mab biosimilar advances and difference in dynamics
  • Future trends and market forecast

HERVE DUMAS, Director - Patient Care Solution Lead, UCB

15:20 – Afternoon Tea/Coffee

LEGAL

15:40 – Legal aspects of AI in pharma
Speaker TBC

BIG DATA

16:10 Panel Discussion: Big Pharma, Big Data - Big Deal? Yes, Really!

  • Usage of Big Data for increase in ROI’s and data optimisation
  • Making Big Data useful: Practical approaches
  • Usage of Big Data for increase in ROI’s and data optimisation
  • Path from data analytics to precision medicine
  • What are the challenges in combining comprehensive data, collected over time, from genetics, environment and lifestyle, to advance disease understanding and interception, aid drug discovery and ensure delivery of appropriate therapies?

Moderator:
PAUL HARTIGAN, CEO, PharmiWeb Solutions


Panellists:
MARGARET McDONALD, Senior Director, Real World Data & Analytics, Patient & Health Impact, PFIZER (USA)

HERVE DUMAS, Director - Patient Care Solution Lead, UCB
MARIE MONTOYA, Director, M Montoya Consultancy

16:50 Chairperson’s closing remarks and end of conference

17:00 – End of the Pharma AI & IoT 2018

MARGARET McDONALD

Senior Director, Real World Data & Analytics, Patient & Health Impact

PFIZER (USA)

SHWEN GWEE

Head of Digital Strategy, Global Clinical Operations

Biogen (USA)

JAMES WEATHERALL

Executive Director and Head of Advanced Analytics Centre

AstraZeneca

DARREN GREEN

Director, Molecular Design UK, RD Platform Technology & Science

GSK

HERVE DUMAS

Director - Patient Care Solution Lead

UCB

GABOR PURMAN

Associate Director Global Respiratory Development in Patient Solutions Team

Teva Pharmaceuticals

PETER RUTHERFORD

Medical Lead, Renal Orphan

Vifor Pharma

NATHALIE LAHITTE

Digital Marketing Manager

Lundbeck

SHERAZ MAJEED

Palliative Medicine Consultant

NHS

SLAVA AKMAEV

Senior Vice President & Chief Analytics Officer

BERG (USA)

Slava Akmaev, Ph.D., is the Senior VP and Chief Analytics Officer at BERG. He is the industry leader in AI and machine learning applications in life sciences and healthcare.  Dr. Akmaev is an advocate for data driven research and promotes wider utility of advanced mathematical modeling techniques in pharmaceutical and clinical research.

FINN CATLING

ACCS Anaesthetics CT1 Doctor

University College London Hospitals NHS Foundation Trust

RAMINDERPAL SINGH

Vice President, Head of Microbiome Division

Eagle Genomics

JORGE ARMANET M

CEO & Co-Founder

HealthUnlocked

Jorge Armanet is CEO and Co-Founder of HealthUnlocked, the global social health platform. He is a technology and media entrepreneur with more than 15 years of international experience in technology and healthcare. Jorge founded HealthUnlocked to transform how people access health information, shifting the emphasis from providers to patients, and from doctors to data. He holds a MPhil in Innovation, Strategy and Organization from Cambridge University, a Master in Digital Media at Goldsmiths (University of London) and an Economics and Engineering/Sciences degree from the Catholic University of Chile

PAUL MICHAEL AGAPOW

Head of Translational Bioinformatics, Data Science Institute

Imperial College London

PAUL HARTIGAN

CEO

PharmiWeb Solutions

MARIE MONTOYA

Director

M Montoya Consultancy

AXEL SCHUMACHER

Co-Founder & CEO

Project Shivom

PASQUALE FEDELE

CEO & Founder

LIQUIDWEB

RYO SAKAI

Data Visualization & Scientific Communications Lead

PharmiWeb Solutions

ORGANISED BY

Virtue Insight

Virtue Insight equips business professionals around the world with the latest indepth industry knowledge and provides networking opportunities in the telecom, infrastructure and pharmaceutical industry. Our aim is to provide a platform to share knowledge and insights and provide our event attendees to network effectively and deliver maximum ROI by make new business alliances. We strive to produce high quality conferences which include the latest topics which are delivered by world class leaders of the industry.

Our motto is to offer our customers the expertise and connections for a profitable business. Our events encompass an optimum chance to gain maximum value in terms of networking and an opportunity to sponsor and exhibit to attract new business alliances.

SUPPORTED BY

Going To Meet

Conference Locate

Clocate.com is a leading international directory for worldwide conferences and exhibitions. Clocate.com is equipped with a unique and comprehensive search that helps you find easily any event in any category or location. Each event includes detailed information, like, description, dates, location, map, prices, link to the official event's  website and more...

If you search for a conference or exhibition in areas such as Industry and manufacturing, Health and medicine, Technology and IT, Business and finance, sciences, education, services (banking, insurance, tourism, Hospitality and more), government, environment, life style and arts, you'll find it in Clocate.com.

FOLLOW US

You Tube

Facebook

Linked in

Twitter

Partnering with Virtue Insight means more than making the right contacts. It means being an insider. It means being connected to the right people with the right level of influence, and it means you are allied with a globally respected organization and leaders in the industry.?


Sponsorship, exhibiting and advertising packages are designed to provide a solid platform to help you stand out and make an impact. Our programs allow you to achieve your marketing goals and deliver a maximum return on your investment. We have developed convenient and customizable packages to help your organization meet its objectives and reach your target market.


Why Sponsor / Exhibit:

PROFIT: To Maximize
MARKET SHARE: Defending and Increasing Market Share
COMPETITION: To attach and defend against competition


Benefits:

  • Generating sales leads
  • Build brand image
  • Maintaining customer relations
  • Consolidating business relationships
  • Accessing new and emerging markets
  • Obtaining technical knowledge
  • Leverages the events extensive marketing campaign to add value to your organisations marketing strategy and budget leading up to the event
  • Live product demonstration to test market responses
  • Facilitating quick market penetration
  • Reach important targeted commercial prospects face to face in a social, relaxed environment. The ideal platform to build strong business friendships Strengthen your market position


Our conferences offer not only a unique combination of benefits (as listed above) to enable the sponsor/exhibitor to communicate the message but also a major opportunity that other forms of selling or media cannot provide.


Contact Us Today

UK
Email - sponsor.uk@virtueinsight.com
Tel: +44-2036120886


INDIA
Email - sponsor@virtueinsight.com
Tel: +91 44 64536444


Our highly researched conference agenda delivers all the latest information and our world-class speakers attract delegates from around the world to attend. We aim for our attendees to be equipped with knowledge of latest developments and enable them to network with the industry key personnel.


What is the format of our conference programme?
The conference programme consists of world-class keynote addresses, case study presentations and panel discussions.


What are the benefits of attending?

  • Meet your peers in an interactive, discussion-based format designed to maximize knowledge transfer and networking
  • Enjoy our informal networking at drinks and lunch
  • Meet the leading solution providers in the market to forge partnerships and discover solutions
  • Receive electronic versions of the conference documentation for use of reference post-event.
  • Get ideas for?training topics?that you might want to present as professional development sessions to others in your workplace.
  • Observe speakers from the perspective of seeing what works really well so you can learn new public speaking techniques and strategies that you can apply when doing your own presentations.
  • Learn what not to do in presentations if you end up sitting through any sessions that fail to be engaging or informative.
  • Delegates also benefit from discounted rates onfuture event attendance


For more information or to register at the event please contact us TODAY:


Contact Us Today

UK
Email - delegate.uk@virtueinsight.com
Tel: +44-2036120886


INDIA
Email - delegate@virtueinsight.com
Tel: +91 44 64536444

Introductory Offer (3 delegate places for the price of 2):- A huge saving of £600 - (Limited seats left) - You can simply email or call and book your conference delegate seats on – TEL: +44 2036120886. Email – delegate.uk@virtueinsight.com

Super Early Discount (30th January 2018 - 8th May 2018):-
Conference Delegate Pass (£600 + VAT per delegate) – You can simply email or call and book your conference delegate seats on – TEL: +44 2036120886. Email – delegate.uk@virtueinsight.com


Early Discount (9th May 2018 - 12th June 2018):-
Conference Delegate Pass (£850 + VAT per delegate) – You can simply email or call and book your conference delegate seats on – TEL: +44 2036120886. Email – delegate.uk@virtueinsight.com

Standard Registration (13th June 2018 Onwards) :-
Conference Delegate Pass (£1100 + VAT per delegate) – You can simply email or call and book your conference delegate seats on – TEL: +44 2036120886. Email – delegate.uk@virtueinsight.com


Conference Sponsor & Exhibition Stall –
Should you wish to Sponsor, or purchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply email your interest and queries to – TEL: +44 2036120886. Email – sponsor.uk@virtueinsight.com

Canary Riverside Plaza Hotel

Address:
46 Westferry Circus, Canary Wharf, London, E14 8RS
Phone:
+44 20 7510 1999

No testimonial available..

Close
Welcome
You have been registered successfully!
Close
Close
Enter Password
Submit Close